Showing posts with the label Translate Bio

Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies

Sanofi Pasteur and Translate Bio announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19 disease. Preclinical evaluation of MR…
Subscribe Our Newsletter